Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00271219 · ClinicalTrials.gov registry record · Phase 3
RCT Comparing Methadone and Buprenorphine in Pregnant Women
A Phase 3 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 3
- Development phase
- 175
- Enrollment target
NCT00271219: Completed Phase 3 study, sponsored by Johns Hopkins University.
NCT00271219 is a Phase 3 study that has completed, run by Johns Hopkins University. The registered enrollment target is 175 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00271219, a Phase 3 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 175 participants
- Enrollment target
Study Summary
Children born to women who abuse drugs have a high risk of being born with birth defects and developmental problems. Methadone is a drug that is commonly used for treating opioid dependence. However, its use by a pregnant woman can cause severe withdrawal symptoms in a newborn because of the prenatal exposure. The purpose of this study is to evaluate the effectiveness of buprenorphine, another drug, versus methadone in reducing withdrawal symptoms in children born to opioid-dependent women.
Interventions
- DRUG Methadone
- DRUG Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2005-07 |
| Est. Completion | 2010-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00271219
The ClinicalTrials.gov registry entry for NCT00271219 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methadone is the first listed.
NCT00271219 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00271219 about?
NCT00271219 is a clinical study titled "RCT Comparing Methadone and Buprenorphine in Pregnant Women". Children born to women who abuse drugs have a high risk of being born with birth defects and developmental problems. Methadone is a drug that is commonly used for treating opioid dependence. However, its use by a pregnant woman can cause severe withdrawal symptoms in a newborn because of the prenata...
What is the current status of trial NCT00271219?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 175 participants. The study started on 2005-07. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00271219?
The interventions under investigation include: Methadone (DRUG), Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT00271219?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.